Moderna, Inc. (MRNA) vs Sanofi (SNY)

A side-by-side comparison of Moderna, Inc. and Sanofi across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 3, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — MRNA vs SNY

growth of $100 · dividends reinvested · last 8y
MRNA +921.6% (+33.7%/yr)SNY +25.6% (+2.9%/yr)MRNA compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $1002020202220242026$1,022$126
MRNA SNY

MRNA vs SNY: by the numbers

  • •SNY is the larger company ($95.86B vs $75.39B market cap).
  • •SNY is profitable (8.10% net margin) while MRNA runs a net loss (-141.43%).
  • •MRNA grew revenue faster over the past five years (19.33% vs 4.96% CAGR).
  • •SNY pays a dividend (6.06% yield), while MRNA has no payments in the available dividend history.

Metrics side by side

Valuation

MetricMRNASNY
P/S ratio33.841.69
P/B ratio11.151.21
EV / EBITDAN/A9.26

Profitability

MetricMRNASNY
Gross margin55.35%73.01%
Operating margin-158.13%14.74%
Net margin-141.43%8.10%
ROE-46.61%5.82%
ROIC-39.16%5.42%

Dividends

MetricMRNASNY
Dividend yieldN/A6.06%

Growth (annualized)

MetricMRNASNY
Revenue CAGR (5Y)19.33%4.96%
EPS CAGR (5Y)N/A-8.92%
FCF CAGR (5Y)N/A12.83%
Total return CAGR (5Y)-11.04%0.63%

Frequently asked

Which has grown faster, MRNA or SNY?
Over the past five years, MRNA grew revenue faster — MRNA at a 19.33% CAGR versus SNY at 4.96%.
Does MRNA or SNY pay a bigger dividend?
SNY pays a dividend (6.06% yield), while MRNA has no payments in the available dividend history.
Is MRNA or SNY more profitable?
SNY runs the higher net margin — MRNA at -141.43% versus SNY at 8.10%.
How have MRNA and SNY total returns compared?
Over the past 5 years, MRNA delivered -11.04% and SNY delivered 0.63% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 3, 2026.